EcoDrugPlus

Toll Pathway Signalling Nf-Kappab Relish-Like Transcription Factor

Ensembl ID : AGAP009515
Gene Symbol: REL1
1 External references
68 Possible Orthologues:

Autophagy Related Tor Protein (Target Of Rapamycin)

Ensembl ID : AGAP007873
Gene Symbol: TOR
1 External references
71 Possible Orthologues:

Carboxylesterase

Ensembl ID : AGAP028426
Gene Symbol: COE09941
2 External references
263 Possible Orthologues:

Carboxylesterase

Ensembl ID : AGAP028696
Gene Symbol: COE09895
1 External references
266 Possible Orthologues:

Carboxylesterase

Ensembl ID : AGAP002090
Gene Symbol: COE16738
1 External references
266 Possible Orthologues:

Carboxylesterase

Ensembl ID : AGAP010917
Gene Symbol: COE09916
1 External references
263 Possible Orthologues:

Carboxylesterase

Ensembl ID : AGAP010390
Gene Symbol: COE12O
1 External references
262 Possible Orthologues:

Carboxylesterase

Ensembl ID : AGAP005834
Gene Symbol: COEJHE2E
1 External references
265 Possible Orthologues:

Carboxylesterase

Ensembl ID : AGAP011366
Gene Symbol: COE18026
2 External references
263 Possible Orthologues:

Carboxylesterase

Ensembl ID : AGAP006727
Gene Symbol: COEAE6G
1 External references
267 Possible Orthologues:

Carboxylesterase Alpha Esterase

Ensembl ID : AGAP006725
Gene Symbol: COEAE3H
1 External references
267 Possible Orthologues:

Cyclin A

Ensembl ID : AGAP012413
Gene Symbol: CYCA
1 External references
412 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).